Holen Sie sich die Stockscreener-App
80.04
5.57%
4.22
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
1 Reason to Sell DexCom Stock, and 1 Reason to Buy - Yahoo Finance
DexCom (NASDAQ:DXCM) Trading 7.3% HigherStill a Buy? - MarketBeat
Orion Portfolio Solutions LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Ōura closes $200M series D, Dexcom invests $75M - BioWorld Online
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada - MSN
Oura boosts valuation to $5.2B in latest funding round (NASDAQ:DXCM) - Seeking Alpha
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement - Business Wire
UPC latest: CoA decision has retroactive effect | Dexcom defeat | 2025 predictions - Managing Intellectual Property
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024DXCM - The Eastern Progress Online
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Dexcom implements GenAI into glucose biosensor devices - Yahoo Finance
Dexcom adds generative AI to over-the-counter CGMs - MedTech Dive
Insiders At DexCom Sold US$18m In Stock, Alluding To Potential Weakness - Simply Wall St
AI-Driven Glucose Biosensing: Dexcom’s (DXCM) Path To A Comeback - Yahoo Finance
Dexcom director Bridgette Heller sells shares for $76,870 By Investing.com - Investing.com Australia
Dexcom's COO Jacob Leach sells $57,191 in stock By Investing.com - Investing.com South Africa
Dexcom director Bridgette Heller sells shares for $76,870 - Investing.com India
Dexcom's COO Jacob Leach sells $57,191 in stock - Investing.com
Dexcom launches generative AI platform for glucose biosensing - Mass Device
Dexcom Rolls Out GenAI Platform for Stelo CGM - MPO-mag
Dexcom Launches First-Ever GenAI Platform for Glucose Monitoring, Partners with Google Cloud - StockTitan
Dexcom G7 CGM System Now Covered by Alberta Government for Type 1 & 2 Diabetes Patients - StockTitan
Is Dexcom, Inc. (DXCM) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Dexcom shares up as Diabetes Association updates guidelines - MSN
Lord Abbett & CO. LLC Sells 23,004,568 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
MML Investors Services LLC Reduces Stock Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - MSN
DexCom, Inc. (NASDAQ:DXCM) Short Interest Update - MarketBeat
DexCom's SWOT analysis: cgm maker faces challenges amid stock volatility - Investing.com
Tidal Investments LLC Raises Stock Holdings in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
World Investment Advisors LLC Purchases Shares of 35,066 DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Virtu Financial LLC Buys New Shares in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
M&T Bank Corp Decreases Stake in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Stifel Financial Corp Sells 24,859 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Brokerages Set DexCom, Inc. (NASDAQ:DXCM) Target Price at $98.00 - MarketBeat
DexCom (NASDAQ:DXCM) Price Target Raised to $94.00 - Defense World
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom - The Eastern Progress Online
DexCom Stock Price | DXCM Stock Quote, News, and History - Markets Insider
DexCom, Inc. (NASDAQ:DXCM) Shares Bought by Geode Capital Management LLC - MarketBeat
DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit - The Eastern Progress Online
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc.DXCM - The Eastern Progress Online
Continuous Glucose Monitoring Devices Market Set to Witness Significant Growth by 2024-2031: Dexcom, Inc., - EIN News
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - The Eastern Progress Online
DexCom Inc. stock underperforms Thursday when compared to competitors - MarketWatch
The Gross Law Firm Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineDXCM - Kilgore News Herald
European court rules in favor of Abbott in Dexcom CGM patent spat - Mass Device
Public Employees Retirement System of Ohio Has $9.78 Million Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Quantinno Capital Management LP Decreases Position in DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
Faruqi & Faruqi Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024DXCM - The Eastern Progress Online
Abbott Gets Another Dexcom Patent Revoked At UPC - Law360
Dexcom, Orthofix, Spire Global, and Target Investigation - GlobeNewswire
Dexcom, Orthofix, Spire Global, and Target Investigation Alert: Johnson Fistel, LLP Encourages Long-Term - EIN News
Dexcom Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm - Longview News-Journal
TCW Group Inc. Sells 21,344 Shares of DexCom, Inc. (NASDAQ:DXCM) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc.DXCM - The Eastern Progress Online
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - The Eastern Progress Online
1.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):